Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

被引:658
作者
Laughlin, MJ
Barker, J
Bambach, B
Koc, ON
Rizzieri, DA
Wagner, JE
Gerson, SL
Lazarus, HM
Cairo, M
Stevens, CE
Rubinstein, P
Kurtzberg, J
机构
[1] Case Western Reserve Univ, Univ Hosp Cleveland, Ireland Comprehens Canc Ctr, Cleveland, OH 44106 USA
[2] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA
[4] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA
[5] Roswell Pk Canc Inst, Dept Pediat, Buffalo, NY 14263 USA
[6] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[7] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA
[8] Columbia Univ, Dept Pediat, New York, NY 10027 USA
[9] Babies & Childrens Hosp, Columbia Presbyterian Med Ctr, New York, NY USA
[10] New York Blood Ctr, Lindsley F Kimball Res Inst, Placental Blood Program, New York, NY 10021 USA
[11] Case Western Reserve Univ, Cleveland, OH 44106 USA
关键词
D O I
10.1056/NEJM200106143442402
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Umbilical-cord blood from unrelated donors who are not HLA-identical with the recipients can restore hematopoiesis after myeloablative therapy in children. We studied the use of transplantation of umbilical-cord blood to restore hematopoiesis in adults. Methods: Sixty-eight adults with life-threatening hematologic disorders received intensive chemotherapy or total-body irradiation and then transplants of HLA-mismatched umbilical-cord blood. We evaluated the outcomes in terms of hematologic reconstitution, the occurrence of acute and chronic graft-versus-host disease (GVHD), relapses, and event-free survival. Results: Of the 68 patients, 48 (71 percent) received grafts of umbilical-cord blood that were mismatched for two or more HLA antigens. Of the 60 patients who survived 28 days or more after transplantation, 55 had neutrophil engraftment at a median of 27 days (range, 13 to 59). The estimated probability of neutrophil recovery in the 68 patients was 0.90 (95 percent confidence interval, 0.85 to 1.0). The presence of a relatively high number of nucleated cells in the umbilical-cord blood before it was frozen was associated with faster recovery of neutrophils. Severe acute GVHD (of grade III or IV) occurred in 11 of 55 patients who could be evaluated within the first 100 days after transplantation. Chronic GVHD developed in 12 of 33 patients who survived for more than 100 days after transplantation. The median follow-up for survivors was 22 months (range, 11 to 51). Of the 68 patients, 19 were alive and 18 of these (26 percent) were disease-free 40 months after transplantation. The presence of a high number of CD34+ cells in the graft was associated with improved event-free survival (P = 0.05). Conclusions: Umbilical-cord blood from unrelated donors can restore hematopoiesis in adults who receive myeloablative therapy and is associated with acceptable rates of severe acute and chronic GVHD. (N Engl J Med 2001;344:1815-22.) Copyright (C) 2001 Massachusetts Medical Society.
引用
收藏
页码:1815 / 1822
页数:8
相关论文
共 37 条
  • [1] Positivity in a modified mixed leukocyte reaction test correlates with molecular HLA-C disparity in prediction of unrelated bone marrow transplantation outcome
    Bishara, A
    Brautbar, C
    Cohen, I
    Nagler, A
    [J]. HUMAN IMMUNOLOGY, 1999, 60 (09) : 833 - 839
  • [2] Buchner T, 1997, Curr Opin Oncol, V9, P18
  • [3] Placental and/or umbilical cord blood: An alternative source of hematopoietic stem cells for transplantation
    Cairo, MS
    Wagner, JE
    [J]. BLOOD, 1997, 90 (12) : 4665 - 4678
  • [4] Pathophysiology and treatment of graft-versus-host disease
    Flowers, MED
    Kansu, E
    Sullivan, KM
    [J]. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (05) : 1091 - +
  • [5] Outcome of cord-blood transplantation from related and unrelated donors
    Gluckman, E
    Rocha, V
    BoyerChammard, A
    Locatelli, F
    Arcese, W
    Pasquini, R
    Ortega, J
    Souillet, G
    Ferreira, E
    Laporte, JP
    Fernandez, M
    Chastang, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) : 373 - 381
  • [6] Gomi S, 1997, Nihon Ika Daigaku Zasshi, V64, P307
  • [7] HAN P, 1995, BRIT J HAEMATOL, V89, P733
  • [8] Bone marrow transplants from unrelated donors for patients with chronic myeloid leukemia
    Hansen, JA
    Gooley, TA
    Martin, PJ
    Appelbaum, F
    Chauncey, TR
    Clift, RA
    Petersdorf, EW
    Radich, J
    Sanders, JE
    Storb, RF
    Sullivan, KM
    Anasetti, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (14) : 962 - 968
  • [9] HANSEN JA, 1990, BONE MARROW TRANSPL, V6, P108
  • [10] Huang S, 1998, EXP HEMATOL, V26, P1162